(Press-News.org) DURHAM, N.C. – Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.
Now researchers -- led by Duke Medicine and including team members from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the U.S. Military HIV Research Program and the Thailand Ministry of Health -- have gained additional insights into the workings of the vaccine that help explain why it benefited a third of recipients and left others vulnerable. The findings, reported in the Jan. 10, 2013, issue of the journal Immunity, are providing new options for vaccine designers to strengthen the drug.
"This study shows what types of antibodies the vaccine induced and gives us information that can guide the study of future vaccine trials," said senior author Barton Haynes, M.D., director of the Duke Human Vaccine Institute. "Understanding how this vaccine works is important to develop strategies to make it better."
The research team focused on an HIV vaccine candidate tested in Thailand called ALVAC. In 2009, AIDS researchers reported that the vaccine protected 31.2 percent of study participants from HIV infection. It was an encouraging protection rate, but short of the minimum 50-percent efficacy required to slow the epidemic, which afflicts an estimated 34 million people worldwide.
Since that time, researchers have been studying the vaccine for clues to its successes and failures in the hopes of making improvements. Haynes and colleagues reported last year they had found a correlation between a key antibody response to the drug and a lower risk of infection.
"But that was a correlation of risk, not necessarily a correlation of protection," Haynes said. "We couldn't prove that the antibody was the cause of protection."
In the current study, the researchers have strengthened the association between the vaccine-induced antibodies and found crucial characteristics of the antibodies induced by the vaccine. Analyzing the immune responses produced by three vaccine recipients in the original trial, the researchers isolated four key antibodies that targeted an important site on the HIV virus – a region known as V2.
In spite of variations in the V2 site's structure, the antibodies zeroed in on the virus, specifically binding at a position on the virus' outer coating that was already known for attracting immune warriors called neutralizing antibodies.
But the researchers found that the four vaccine-triggered antibodies worked differently than the neutralizing antibodies. Instead of attacking the virus directly, the vaccine-induced antibodies recognized virus-infected cells and flagged them for an attack by other immune cells.
The findings indicate that these types of V2 antibodies expand the immune system's arsenal against HIV, potentially enhancing the effects of the existing ALVAC vaccine.
"The next step for our research is to explore how to design immunogens to induce antibodies that can have broadly neutralizing activities," said Hua-Xin Liao, M.D., PhD, lead author and research director of Duke Human Vaccine Institute. "Our findings provide new targets for this research."
###
In addition to Haynes and Liao, study authors from Duke include Mattia Bonsignori, S. Munir Alam, Georgia D. Tomaras, M. Anthony Moody, Daniel M. Kozink, Kwan-Ki Hwang, Xi Chen, Chun- Yen Tsao, Pinghuang Liu, Xiaozhi Lu, Robert J. Parks, David C. Montefiori, Guido Ferrari, Justin Pollara, Kevin Wiehe and Nathan I. Nicely.
Other authors include Jason S. McLellan, Zhi-Yong Yang, Kaifan Dai, Marie Pancera, Jason Gorman, Peter D. Kwong, John R. Mascola and Gary J. Nabel of the Vaccine Research Center of the NIH; Mangala Rao, Kristina K. Peachman, Jerome H. Kim and Nelson L. Michael of the Walter Reed Army Institute of Research; Sampa Santra and Norman L. Letvin from Harvard Medical School; Nicos Karasavvas and Sorachai Nitayaphan from U.S. Army Medical Component, Bangkok, Thailand; Supachai Rerks-Ngarm from the Ministry of Public Health, Thailand; Jaranit Kaewkungwal and Punnee Pitisuttithum of Mahidol University, Thailand; James Tartaglia of Sanofi Pasteur; Faruk Sinangil of Global Solutions for Infectious Diseases; Thomas B. Kepler of Boston University School of Medicine; Abraham Pinter of New Jersey Medical School; and Susan Zolla-Pazner of VA New York Harbor Healthcare System and New York University School of Medicine.
This study received support from the Bill & Melinda Gates Foundation; the National Institute of Allergy and Infectious Diseases (AI067854, AI100645); the Department of Veterans Affairs; the U.S. Army; the Medical Research and Material Command; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and the U.S. Department of Defense.
Cold Spring Harbor, NY – A team of cancer researchers at Cold Spring Harbor Laboratory (CSHL) has solved the mystery of how one of the most powerful of the body's natural tumor-suppressing proteins, called Chd5, exerts its beneficial effects.
The findings, published online today in the journal Cell Reports, are important because Chd5 engages processes fundamental to cancer prevention. Conversely, when Chd5 is mutated or missing, an important door is opened to cancer initiation.
"For this reason, figuring out the mechanics of how Chd5 works to prevent cancer can directly ...
We rely on our visual system more heavily than previously thought in determining the causality of events. A team of researchers has shown that, in making judgments about causality, we don't always need to use cognitive reasoning. In some cases, our visual brain—the brain areas that process what the eyes sense—can make these judgments rapidly and automatically.
The study appears in the latest issue of the journal Current Biology.
"Our study reveals that causality can be computed at an early level in the visual system," said Martin Rolfs, who conducted much of the research ...
ARLINGTON, VA, January 10, 2013—A study released today from the upcoming issue of the Journal of the Pediatric Infectious Diseases Society (JPIDS) found that taking early and repeated white blood cell counts (WBC) is critical in determining whether infants have pertussis and which of those children are at highest risk of death from the disease.
In 2010, California reported its highest pertussis rates in 60 years. Murray, et al.'s retrospective study used medical records from five Southern California Pediatric Intensive Care Units between September 2009 and June 2011. ...
GAINESVILLE, Fla. --- Cholera could be contained in Haiti by vaccinating less than half the population, University of Florida researchers suggest in a paper to be published Thursday in the journal Scientific Reports.
The work places UF's Emerging Pathogens Institute in the pro-vaccination camp in an ongoing international debate over how best to contain the two-year-old epidemic that has claimed thousands of lives.
The Centers for Disease Control and Prevention has been skeptical about the effectiveness of vaccination against cholera in this setting. It has instead ...
Teenagers with a low muscular strength have a 30% higher risk of committing suicide before the age of 55 years, and a 65% higher risk of developing psychiatric diseases such as depression of schizophrenia. In addition, a low muscular strength during childhood and adolescence is a strong predictor of early death –i.e. before 55 years of age– from cardiovascular disease. A low muscular strength is as powerful a predictor as obesity and high blood pressure.
This was the conclusion drawn in a study recently published in the Medical Journal –a world-leading medical journal– ...
Philadelphia, PA, January 10, 2013 – Horrific images from One Flew Over the Cuckoo's Nest notwithstanding, modern electroconvulsive therapy (ECT) remains one of the safest and most effective antidepressant treatments, particularly for patients who do not tolerate antidepressant medications or depression symptoms that have failed to respond to antidepressant medications.
Since its introduction in the 1930s, ECT has evolved into a more refined, but more expensive and extensively regulated clinical procedure. Each treatment involves the assembly of a multidisciplinary clinical ...
Boston, Mass. — Researchers at Boston Children's Hospital have found, for the first time that young humans (infants, children and adolescents) are capable of generating new heart muscle cells. These findings refute the long-held belief that the human heart grows after birth exclusively by enlargement of existing cells, and raise the possibility that scientists could stimulate production of new cells to repair injured hearts.
Findings of the study, "Cardiomyocyte proliferation contributes to post-natal heart growth in young humans," were published in Proceedings of the ...
Scientists observed that blocking the expression of the gene TRIP-Br2 in mice protects them against obesity and insulin resistance. The study shows that the gene modulates fat storage by regulating energy expenditure and lipolysis, the process which transforms fat into lipids for the body's energy consumption. If the gene expression is blocked, the mice increase their lipolysis and their energy expenditure, thus reducing their obesity.
Obesity is the result of an alteration in the processes that regulate food absorption and energy production. This alteration tips the ...
This new infrared image from ESO's VISTA telescope shows the globular cluster 47 Tucanae in striking detail. This cluster contains millions of stars, and there are many nestled at its core that are exotic and display unusual properties. Studying objects within clusters like 47 Tucanae may help us to understand how these oddballs form and interact. This image is very sharp and deep due to the size, sensitivity, and location of VISTA, which is sited at ESO's Paranal Observatory in Chile.
Globular clusters are vast, spherical clouds of old stars bound together by gravity. ...
Research at the University of Edinburgh tracked electrical signals in the part of the brain linked to spatial awareness.
The study could help us understand how, if we know a room, we can go into it with our eyes shut and find our way around. This is closely related to the way we map out how to get from one place to another
Scientists found that brain cells, which code location through increases in electrical activity, do not do so by talking directly to each other. Instead, they can only send each other signals through cells that are known to reduce electrical activity.
This ...
